BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vexim 

75, rue Saint Jean

Balma    31130  France
Phone: 33-05-61-488663 Fax: 33-05-61-489519


SEARCH JOBS




Industry
Medical Device






 Company News
Vexim Reports 1-year Results Of Comparative Randomized Study Of SpineJack Versus Balloon Kyphoplasty 4/17/2015 9:08:30 AM
Vexim Announces 2015 First Quarter Sales Results 4/16/2015 12:13:31 PM
Vexim: 2014 Annual Results 3/24/2015 9:17:30 AM
Vexim Obtains CE Approval To Market Masterflow Injection System In Europe 3/11/2015 12:03:08 PM
Vexim Release: Excellent Long Term Performances Of Spinejack Supported By A 24-Month Follow-Up Clinical Study 3/2/2015 12:24:21 PM
Vexim Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency 2/19/2015 11:36:40 AM
Vexim Patents Are Now Granted In Europe, US And China For MASTERFLOW, The New High-Performance Cement Delivery System 2/12/2015 12:40:29 PM
Vexim Announces The First Sales Of Its Masterflowtm Injection System In The United States 2/2/2015 9:31:30 AM
Vexim 2014 Sales Increase Sharply By 69% To €10.3 Million 1/26/2015 11:12:26 AM
Vexim Obtains FDA Approval To Market Masterflow™ Injection System In The United States 12/10/2014 1:09:55 PM
123456